Clinical trial · Observational
TME Neoadjuvant Breast Registry
TME Neoadjuvant Breast Registry (The NEAT Registry)
NCT02596724CI-TRIAL-00019715unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective observational registry that links results of the genomic and other molecular testing to treatment response and survival measures in patients who have been diagnosed with breast cancer and who are targeted for neo-adjuvant therapy. Analysis includes how tests impact treatment decisions and outcomes.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Genomic and/or molecular testing of blood or tissue | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Pathologic response and/or endocrine sensitivity
- timeFrame
- Post surgical treatment--usually within 4 months
Secondary outcomes (1)
- measure
- Metastasis-free/relapse-free survival in molecular subgroups
- timeFrame
- 5 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with histologically proven invasive breast cancer who have started or are scheduled to start neo-adjuvant chemotherapy or endocrine therapy * Ages 18-90 * Written informed consent Exclusion Criteria: * Patients who have had excisional biopsy or axillary dissection * Patients with confirmed metastatic disease * Patients who have had recent chemotherapy
References
Publications (0)
Data not yet available
No reference posted for this study.